WITHDRAWN: Tamoxifen for early breast cancer.
BACKGROUND: There have been many randomised trials of adjuvant tamoxifen among women with early breast cancer, and an updated overview of their results is presented. OBJECTIVES: In this report, the Early Breast Cancer Trialists' Collaborative Group present their third 5-yearly systematic overv...
| Main Author: | |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2008
|